Literature DB >> 6972993

Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.

E M Lafer, J Rauch, C Andrzejewski, D Mudd, B Furie, B Furie, R S Schwartz, B D Stollar.   

Abstract

Hybridomas the produce anti-DNA autoantibodies were prepared from spleen cells of unimmunized MRL/1 mice, a strain that spontaneously develops severe systemic lupus erythematous (SLE). Reactivities of these monoclonal antibodies with a wide range of polynucleotides prompted tests of their reactions with phospholipids which, like polynucleotides, contain diester-linked phosphate groups in their backbones. In competitive radioimmunoassays, cardiolipin, phosphatidic acid, and phosphatidyl glycerol blocked the binding of these hybridoma antibodies to denatured DNA. These phospholipids also specifically inhibited the reaction between a hybridoma antibody and a site-specific anti-idiotypic antibody. The antinuclear reaction of one of these antibodies was specifically inhibited by cardiolipin. This same antibody prolonged the activated partial thromboplastin time in a manner characteristic of a lupus anticoagulant, presumably by binding to phospholipid in the test system. The polyspecific reactivity of a single molecular species of lupus autoantibody suggests that some of the diverse serological abnormalities of SLE may be a result of the binding of certain autoantibodies to a phosphodiester-containing epitope that is present in diverse biological molecules.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972993      PMCID: PMC2186121          DOI: 10.1084/jem.153.4.897

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Autoimmune hemolytic anemia.

Authors:  J V Dacie
Journal:  Arch Intern Med       Date:  1975-10

2.  NIH conference. Systemic lupus erythematosus: evolving concepts.

Authors:  J L Decker; A D Steinberg; J L Reinertsen; P H Plotz; J E Balow; J H Klippel
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

3.  A clinical study of the lupus anticoagulant.

Authors:  M A Schleider; R L Nachman; E A Jaffe; M Coleman
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

4.  A DNA antigen that reacts with antisera to cardiolipin.

Authors:  M Guarnieri; D Eisner
Journal:  Biochem Biophys Res Commun       Date:  1974-05-20       Impact factor: 3.575

5.  Thyroid-stimulating immunoglobulins in Graves' disease.

Authors:  B R Smith; R Hall
Journal:  Lancet       Date:  1974-08-24       Impact factor: 79.321

Review 6.  Disordered immunologic regulation and autoimmunity.

Authors:  N Talal
Journal:  Transplant Rev       Date:  1976

7.  The detections of anti-DNA and DNA/anti-DNA complexes.

Authors:  B D Stollar
Journal:  Scand J Rheumatol Suppl       Date:  1975

8.  Isoelectric focusing in agarose.

Authors:  C A Saravis; N Zamcheck
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

9.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease.

Authors:  D Koffler; R Carr; V Agnello; R Thoburn; H G Kunkel
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  140 in total

1.  Lupus autoantibodies 101: one size does not fit all; however, specificity influences pathogenicity.

Authors:  M P Madaio
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

Review 2.  The biochemistry and genetics of DNA and anti-DNA antibodies.

Authors:  B D Stollar
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

3.  Addison's disease, hypertension, renal and hepatic microthrombosis in 'primary' antiphospholipid syndrome.

Authors:  S Inam; K Sidki; A R al-Marshedy; R Judzewitsch
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

4.  Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.

Authors:  K Pirner; A Rascu; W Nürnberg; A Rubbert; J R Kalden; B Manger
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

5.  Disease activity in systemic lupus erythematosus related to a range of antibodies binding DNA and synthetic polynucleotides.

Authors:  D A Isenberg; C Dudeney; W Williams; A Todd-Pokropek; B D Stollar
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

6.  Anti-Klebsiella K30 phospholipid antibodies in systemic lupus erythematosus: antigen cross-reactions and idiotypic sharing with antibodies to DNA and Klebsiella K30 polysaccharide.

Authors:  G D Harkiss; F M Hendrie; D Thompson
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

7.  Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids.

Authors:  M Sutjita; A Hohmann; R Comacchio; J Bradley
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

8.  Generation of monoclonal anti-dermatan sulphate antibodies cross-reacting to calf thymus DNA.

Authors:  K Ohnishi; A Sagawa; T Nakabayashi; A Ohmoto; M Yoshikawa; I Watanabe; M Mukai; I Yasuda; S Nakagawa
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

9.  Human multiple organ-reactive monoclonal autoantibody recognizes growth hormone and a 35,000-molecular weight protein.

Authors:  J Satoh; K Essani; P R McClintock; A L Notkins
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

10.  Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.

Authors:  Z M Sthoeger; B Tartakovsky; Z Bentwich; E Mozes
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.